Navigation Links
PDL BioPharma Acquires Portfolio of Diabetes Royalty Rights and Milestones from Depomed
Date:10/21/2013

has diabetes and 1.9 million new diagnoses occur per year in people aged 20 years and older.[i] "The acquisition of Depomed's diabetes royalty rights is a significant addition to our income generating assets," said John McLaughlin, chief executive officer of PDL BioPharma. "This acquisition allows PDL to participate in a potentially lengthy, diversified stream of royalties on products in different classes across the diabetes area. Our goal is to be the financial partner of choice to leading life science companies and other institutions seeking to access non-dilutive capital by monetizing their royalty assets, and we are actively looking to expand our portfolio."

Glumetza, a once-daily extended release metformin product approved for the treatment for adults with type 2 diabetes, is licensed by Depomed to Santarus, Inc. in the United States. For the year ended 2012, Depomed reported royalty revenues of $42.8 million based upon net sales of Glumetza by Santarus. PDL will receive Depomed's royalties on net sales of Glumetza of 32 percent for the remainder of 2013 and full year 2014, and 34.5 percent in 2015 and beyond. In the event of generic entry of a Glumetza product in the United States, PDL will share proceeds equally with Santarus based on a gross margin split. In addition to Glumetza royalties due from Santarus, PDL will receive Depomed's royalties due from Valeant Pharmaceuticals for sales in Canada and from LG Life Sciences for sales in Korea.

Janumet XR is Merck's fixed-dose combination product for type 2 diabetes containing sitagliptin, an extended release metformin that was approved by the FDA in February 2012. Depomed granted Merck a license as well as other rights to certain of its patents directed to metformin extended release technology for Janumet XR. PDL will receive Depomed's very low single digit royalty on Merck's net sales of Ja
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PDL BioPharma Provides $60 Million in Financing to LENSAR
2. Global Biopharma Mergers & Acquisition and Deal Making Report 2013: Understanding the Latest Trends to Optimize Future Strategy
3. PDL BioPharma to Present at the 4th Annual Credit Suisse Small/Mid Cap Conference
4. PDL BioPharma Provides Third Quarter 2013 Revenue Guidance of $97 Million
5. Market Research Reports: Biologics, Biosimilars, Bioseparation Systems for Biopharmaceutical Markets
6. New HAE Drug Candidate from Dyax Produced by Laureate Biopharma
7. Morning Research: BioCryst Pharma Inc., Questcor Pharma Inc., PDL BioPharma Inc., and Amgen Inc.
8. Robbins Arroyo LLP Is Investigating the Directors and Officers of Navidea Biopharmaceuticals, Inc.
9. PDL BioPharma Announces Second Quarter 2013 Financial Results
10. Pre-Market Analysis: MannKind, Galena Biopharma, Ariad Pharma, and Novavax
11. Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2013 On August 7, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... Quietly, sedately, Morocco,s pharmaceutical sector is shining. ... is strong, with a well-developed base of local producers ... One place where the quality of Moroccan pharma ... quietly become the second largest African exporter of drugs ... Moroccan pharma companies have been making inroads as exporters ...
(Date:7/31/2015)... CHICAGO , July 31, 2015 ... Composition Analyzers Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy ... and Hydrostatic Weighing) - Global Analysis & Forecast to ... Market was pegged at $911.1 Million 2014 and is ... at a CAGR of 9.4% from 2014 to 2019. ...
(Date:7/30/2015)... IRIDEX Corporation (NASDAQ: IRIX ) today ... financial results after the market closes on Thursday, ... the Company will host a conference call with the ... Thursday, August 6, 2015 to discuss ... Interested parties may access the live conference ...
Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2
... ANTONIO, May 10, 2012 /PRNewswire-iReach/ -- ... a unique and innovative chronic wound treatment device, ... (Commerce City, CO) existing Federal Supply Schedule (FSS) ... (VA). The TransCu O2 ® , a noninvasive, ...
... LOUIS, May 9, 2012 Young Innovations, Inc. (NASDAQ ... declared a quarterly dividend of $0.04 per share, payable ... May 23, 2012. Young Innovations develops, manufactures ... hygienists, dental assistants and consumers. The Company,s consumables product ...
Cached Medicine Technology:New Chronic Wound Treatment Device Receives Award from Veterans Healthcare Program 2New Chronic Wound Treatment Device Receives Award from Veterans Healthcare Program 3Young Innovations, Inc. Board Of Directors Declares Quarterly Dividend 2
(Date:8/1/2015)... ... August 01, 2015 , ... The condition where veins are ... and women often causing pain and discomfort. Those who spend a lot of time ... Northeast Houston Vein Center is doing what it can to create awareness and provide ...
(Date:8/1/2015)... ... , ... Tina Wilcoxson, owner of Freeport Maine’s Royal River Natural Foods, was ... National Retail Federation, the largest retail trade association in the world, for her “advocacy ... to be named as such. According to the NRF’s website, Retail Champions are “Main ...
(Date:8/1/2015)... ... August 01, 2015 , ... Professional Orthopedic and ... has acquired Premier Physical Therapy & Wellness (“Premier”) — with 13 locations in ... , “Our acquisition of Premier Physical Therapy & Wellness solidifies Professional as the ...
(Date:8/1/2015)... ... August 01, 2015 , ... Lume Wellness creators Alex, Robert, ... to download on the Apple AppStore. , The app is designed to track ... acting as a tool to view personal health and use this information for positive ...
(Date:8/1/2015)... (PRWEB) , ... August 01, 2015 , ... “ reTXT ... look at the latest and coolest applications on the market for iOS, Android, and ... and shared with viewers allows users to clarify, edit and delete any message including ...
Breaking Medicine News(10 mins):Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Local Retail Advocate Wins National Recognition 2Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2
... scientific, and business arenas convened for the 17th ... Session. Held April 23-25th 2009, this event ... (A4M; www.worldhealth.net ), the academic leader in ... extension that impacts more than 550,000 physicians and ...
... Nash Corporation (Nasdaq: KNSY ) is scheduled ... Lynch 2009 Health Care Conference at The Palace Hotel ... W. Kaufmann, Kensey Nash,s President & CEO, will deliver ... To hear the live webcast of the Kensey ...
... Importance of Washing their HandsANN ARBOR, Mich., April ... pandemic continue to surface internationally. New cases have ... and eight countries. This includes a twenty-three month ... first reported fatality outside of Mexico.(Logo: ...
... 30 The Coalition for Pulmonary Fibrosis (CPF) is pleased ... Marsden on Country Music Television (CMT),s CMT Insider ... p.m. CDT. The interview was taped at the recent ... the family of the late Dennis Linde in Nashville at ...
... developing leukemia as a side effect of a drug for ... a study presented as part of the Late-breaking Science Program ... Seattle, April 25 - May 2, 2009.Mitoxantrone is an immunosuppressant ... of advancing MS. It is one of only two drugs ...
... Kris Clark, Ph.D., R.D., F.A.C.S.M., Clarifies This Year,s Popular Diet ... Track for Spring/SummerWASHINGTON, April 30 Spring. It,s the ... and renew the weight-loss vows we made back in January ... Each year, millions of Americans follow the latest and ...
Cached Medicine News:Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 2Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 3Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 4Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 5Health News:Hand Washing Can Help Fight Against the Swine Flu 2Health News:Actor James Marsden To Appear on CMT Insider May 2, Talk About Pulmonary Fibrosis 2Health News:Actor James Marsden To Appear on CMT Insider May 2, Talk About Pulmonary Fibrosis 3Health News:Risk of Leukemia with Multiple Sclerosis Drug Higher Than Thought 2Health News:Do Fad Diets Really Work? 2Health News:Do Fad Diets Really Work? 3Health News:Do Fad Diets Really Work? 4
... This latest sensor array ... average inter-channel spacing of just ... array is particularly useful when ... as Synthetic Aperture Magnetometry (SAM) ...
... Our unique Model Practice Eye can be used ... binocular indirect ophthalmoscopy, non-contact fundus biomicroscopy. ... a synthetic rubber which closely resembles the human ... texture of the sclera. The lens and ...
... Bi-Ostetic is a cost-effective synthetic ... Based on Tricalcium Phosphate (TCP) and ... of human bone. BAB formulates the ... enhance bone regeneration. This formulation provides ...
... pacing wire design offers reliable ... in the atrium and ventricle ... in one lead design. The ... ventricle are color-coded for easy ...
Medicine Products: